MedKoo Cat#: 412360 | Name: Carminomycin II

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Carminomycin II is a very toxic anthracycline-type antineoplastic related to DAUNORUBICIN, obtained from Actinomadura carminata.

Chemical Structure

Carminomycin II
Carminomycin II
CAS#50935-05-2 (II)

Theoretical Analysis

MedKoo Cat#: 412360

Name: Carminomycin II

CAS#: 50935-05-2 (II)

Chemical Formula: C33H41NO13

Exact Mass: 659.2578

Molecular Weight: 659.69

Elemental Analysis: C, 60.08; H, 6.26; N, 2.12; O, 31.53

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Synonym
Carminomycin II; Carminomicin 2
IUPAC/Chemical Name
8-acetyl-10-((4-amino-5-(3-hydroxy-1-((1-hydroxypropan-2-yl)oxy)butoxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-1,6,8,11-tetrahydroxy-7,8,9,10-tetrahydrotetracene-5,12-dione
InChi Key
DNHXZQIEIKSDIK-UHFFFAOYSA-N
InChi Code
InChI=1S/C33H41NO13/c1-13(36)8-22(44-14(2)12-35)47-32-15(3)45-23(9-19(32)34)46-21-11-33(43,16(4)37)10-18-25(21)31(42)27-26(29(18)40)28(39)17-6-5-7-20(38)24(17)30(27)41/h5-7,13-15,19,21-23,32,35-36,38,40,42-43H,8-12,34H2,1-4H3
SMILES Code
CC(CC(OC1C(OC(OC2CC(Cc3c2c(O)c4c(C(c5c(C4=O)c(O)ccc5)=O)c3O)(C(C)=O)O)CC1N)C)OC(CO)C)O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 659.69 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Gause GF. Antitumor antibiotic carminomycin. Z Allg Mikrobiol. 1980;20(3):219-25. PMID: 6158803. 2: Woldemichael GM, Turbyville TJ, Linehan WM, McMahon JB. Carminomycin I is an apoptosis inducer that targets the Golgi complex in clear cell renal carcinoma cells. Cancer Res. 2011 Jan 1;71(1):134-42. doi: 10.1158/0008-5472.CAN-10-0757. PMID: 21199801; PMCID: PMC3074515. 3: Tevyashova AN, Shtil AA, Olsufyeva EN, Simonova VS, Samusenko AV, Preobrazhenskaya MN. Carminomycin, 14-hydroxycarminomycin and its novel carbohydrate derivatives potently kill human tumor cells and their multidrug resistant variants. J Antibiot (Tokyo). 2004 Feb;57(2):143-50. doi: 10.7164/antibiotics.57.143. PMID: 15112963. 4: Rozencweig M, ten Bokkel Huinink W, Cavalli F, Bruntsch U, Dombernowsky P, Høst H, Bramwell V, Renard G, Van Glabbeke M, Decoster G. Randomized phase II trial of carminomycin versus 4'-epidoxorubicin in advanced breast cancer. J Clin Oncol. 1984 Apr;2(4):275-81. doi: 10.1200/JCO.1984.2.4.275. PMID: 6584561. 5: Kochetkova GV, Gladkikh EG, Ponomarenko VI. Vliianie pH sredy na rost produtsenta karminomitsina i biosintez karminomitsinovogo kompleksa [Effect of the pH of the medium on the growth of a carminomycin producer and on the biosynthesis of the carminomycin complex]. Antibiotiki. 1977 May;22(5):387-91. Russian. PMID: 879720. 6: Crooke ST. A review of carminomycin-a new anthracycline developed in the USSR. J Med. 1977;8(5):295-316. PMID: 338849. 7: Liashenko VA, Shapovalova SP, Aleksander SK, Povarov LS. Protivovirusnoe deĭstvie karminomitsina i nekotorykh ego proizvodnykh [Antiviral action of carminomycin and some of its derivatives]. Antibiotiki. 1978 Nov;23(11):1009-15. Russian. PMID: 214027. 8: Aleksander SK, Liashenko VA, Iakushkina IV. Sravnenie protivoopukholevykh, immunodepressivnykh i toksicheskikh svoĭstv kompleksov karminomitsina s al'buminom razlichaiushchikhsia po soderzhaniiu karminomitsina [Comparison of the antitumor, immunodepressive and toxic properties of carminomycin-albumin complexes differing in carminomycin content]. Antibiotiki. 1981 Apr;26(4):298-302. Russian. PMID: 6894522. 9: Muggia FM, Green MD. New anthracycline antitumor antibiotics. Crit Rev Oncol Hematol. 1991;11(1):43-64. doi: 10.1016/1040-8428(91)90017-7. PMID: 1831987. 10: Young RC, Ozols RF, Myers CE. The anthracycline antineoplastic drugs. N Engl J Med. 1981 Jul 16;305(3):139-53. doi: 10.1056/NEJM198107163050305. PMID: 7017406.